Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter Summaries of opinion (7) Apply Summaries of opinion filter Withdrawn applications (26) Apply Withdrawn applications filter Orphan designations (20) Apply Orphan designations filter Direct healthcare professional communication (4) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (4) Apply Yes filter

Authorisation status

Authorised (330) Apply Authorised filter Refused (3) Apply Refused filter Withdrawn (64) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (1) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (5) Apply PM: decision on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

Referral name

Referral status

European Commission final decision (4) Apply European Commission final decision filter

Referral safety status

Yes (2) Apply Yes filter

Referral type

Article 31 referrals (4) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (4) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (4) Apply Centrally and nationally authorised products (mixed) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Biosimilar Remove Biosimilar filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Accelerated assessment (88) Apply Accelerated assessment filter Additional monitoring (543) Apply Additional monitoring filter Conditional approval (64) Apply Conditional approval filter Orphan medicine (213) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

408 results

Remove all filtersRemove all filters

Keyword Remove keyword

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter

Medicine type Generic Remove Generic filter Exceptional circumstances Remove Exceptional circumstances filter Biosimilar Remove Biosimilar filter

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Sort by

List item

Human medicine European public assessment report (EPAR): Abasaglar (previously Abasria) (updated)

insulin glargine, Diabetes Mellitus
Date of authorisation: 09/09/2014, , Revision: 11, Authorised, Last updated: 22/03/2021
List item

Human medicine European public assessment report (EPAR): Abseamed

epoetin alfa, Anemia, Kidney Failure, Chronic, Cancer
Date of authorisation: 27/08/2007,
Date of refusal: 18/06/2009, , Revision: 22, Authorised, Last updated: 08/10/2019
List item

Human medicine European public assessment report (EPAR): Accofil

filgrastim, Neutropenia
Date of authorisation: 17/09/2014, , Revision: 11, Authorised, Last updated: 24/08/2020
List item

Human medicine European public assessment report (EPAR): Actelsar HCT

telmisartan, hydrochlorothiazide, Essential Hypertension
Date of authorisation: 13/03/2013, , Revision: 12, Authorised, Last updated: 27/01/2021
List item

Veterinary medicine European public assessment report (EPAR): Acticam (updated)

meloxicam, Dogs, Cats
Date of authorisation: 09/12/2008, , Revision: 9, Withdrawn, Last updated: 24/03/2021
List item

Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 10/10/2009, , Revision: 10, Authorised, Last updated: 06/11/2019
List item

Human medicine European public assessment report (EPAR): Alpheon

recombinant human interferon alfa-2a, Hepatitis C, Chronic
Date of refusal: 05/09/2006, , Refused, Last updated: 28/06/2006
List item

Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)

ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019, , Revision: 2, Authorised, Last updated: 23/03/2021
List item

Human medicine European public assessment report (EPAR): Amgevita

adalimumab, Arthritis, Psoriatic, Colitis, Ulcerative, Arthritis, Juvenile Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017, , , Revision: 8, Authorised, Last updated: 12/03/2020
List item

Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan

Amlodipine besilate, valsartan, Hypertension
Date of authorisation: 22/03/2016, , Revision: 6, Authorised, Last updated: 02/02/2021
List item

Human medicine European public assessment report (EPAR): Amsparity

adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease, Hidradenitis Suppurativa
Date of authorisation: 13/02/2020, , , Revision: 1, Authorised, Last updated: 01/12/2020
List item

Human medicine European public assessment report (EPAR): Anagrelide Mylan

Anagrelide hydrochloride, Thrombocythemia, Essential
Date of authorisation: 15/02/2018, , Revision: 2, Authorised, Last updated: 08/06/2020
List item

Human medicine European public assessment report (EPAR): Apixaban Accord

Apixaban, Venous Thromboembolism, Stroke, Arthroplasty
Date of authorisation: 23/07/2020, , Authorised, Last updated: 06/08/2020
List item

Human medicine European public assessment report (EPAR): Aripiprazole Accord

aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015, , Revision: 11, Authorised, Last updated: 21/10/2020
List item

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen)

aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 30/06/2015, , Revision: 10, Authorised, Last updated: 24/06/2020
List item

Human medicine European public assessment report (EPAR): Aripiprazole Sandoz

aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 20/08/2015, , Revision: 8, Authorised, Last updated: 10/07/2020
List item

Human medicine European public assessment report (EPAR): Aripiprazole Zentiva (updated)

aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 25/06/2015, , Revision: 8, Authorised, Last updated: 19/03/2021
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019, , Revision: 2, Authorised, Last updated: 16/09/2020
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide medac

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 17/09/2020, , Authorised, Last updated: 01/10/2020
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 01/04/2020, , Authorised, Last updated: 17/04/2020
List item

Human medicine European public assessment report (EPAR): Atazanavir Krka

atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019, , Authorised, Last updated: 15/05/2019
List item

Human medicine European public assessment report (EPAR): Atazanavir Mylan

atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016, , Revision: 9, Authorised, Last updated: 08/12/2020
List item

Human medicine European public assessment report (EPAR): Atosiban SUN

atosiban (as acetate), Premature Birth
Date of authorisation: 31/07/2013, , Revision: 8, Authorised, Last updated: 11/11/2020
List item

Human medicine European public assessment report (EPAR): Atriance

nelarabine, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 22/08/2007, , , Revision: 24, Authorised, Last updated: 04/12/2020
List item

Human medicine European public assessment report (EPAR): ATryn

Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006, , , Revision: 16, Withdrawn, Last updated: 02/07/2019

Load more

408 results

Human medicine European public assessment report (EPAR): Abasaglar (previously Abasria) (updated)

Human medicine European public assessment report (EPAR): Abseamed

Human medicine European public assessment report (EPAR): Accofil

Human medicine European public assessment report (EPAR): Actelsar HCT

Veterinary medicine European public assessment report (EPAR): Acticam (updated)

Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

Human medicine European public assessment report (EPAR): Alpheon

Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)

Human medicine European public assessment report (EPAR): Amgevita

Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan

Human medicine European public assessment report (EPAR): Amsparity

Human medicine European public assessment report (EPAR): Anagrelide Mylan

Human medicine European public assessment report (EPAR): Apixaban Accord

Human medicine European public assessment report (EPAR): Aripiprazole Accord

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen)

Human medicine European public assessment report (EPAR): Aripiprazole Sandoz

Human medicine European public assessment report (EPAR): Aripiprazole Zentiva (updated)

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord

Human medicine European public assessment report (EPAR): Arsenic trioxide medac

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Human medicine European public assessment report (EPAR): Atazanavir Krka

Human medicine European public assessment report (EPAR): Atazanavir Mylan

Human medicine European public assessment report (EPAR): Atosiban SUN

Human medicine European public assessment report (EPAR): Atriance

Human medicine European public assessment report (EPAR): ATryn